Clinical Trial Update: Transfusion of Red Blood Cells, Tranexamic Acid and Fibrinogen Concentrate for Severe Trauma Hemorrhage [Phase 3]

View source ↗

Summary

Phase 3 trial update assessing transfusion of red blood cells, tranexamic acid, and fibrinogen concentrate for severe trauma hemorrhage has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemorrhagic Shock

Drugs mentioned

• Fibrinogen concentrate (Fibrinogen concentrate)
• TRANEXAMIC ACID (TRANEXAMIC ACID)
• red blood cells (red blood cells)

Snippet

Sponsor: Cristina Martinez | Conditions: Hemorrhagic Shock | Phase 3 | Status: COMPLETED